background
middl
east
respiratori
syndrom
coronaviru
merscov
emerg
saudi
arabia
caus
epidem
middl
east
public
health
england
phe
manchest
one
two
phe
centr
uk
perform
test
merscov
result
phe
manchest
mer
surveil
present
report
method
retrospect
data
collect
return
travel
middl
east
fit
phe
mer
case
definit
respiratori
sampl
test
respiratori
virus
merscov
use
inhous
rtpcr
assay
result
four
hundr
twentysix
sampl
patient
test
mer
cov
respiratori
virus
merscov
infect
identifi
pcr
fiftysix
percent
sampl
pcr
posit
viral
bacteri
pathogen
influenza
predomin
viru
sixtytwo
percent
patient
pathogen
identifi
highest
posit
sputum
sampl
patient
multipl
sampl
demonstr
diagnost
yield
conclus
although
case
mer
identifi
major
patient
influenza
infect
oseltamivir
treatment
indic
isol
warrant
sputum
sampl
use
diagnos
respiratori
virus
diagnost
yield
patient
multipl
sampl
novel
coronaviru
middl
east
respiratori
syndrom
coronaviru
merscov
emerg
saudi
arabia
first
case
saudi
nation
admit
june
pneumonia
renal
failur
result
fatal
outcom
case
later
identifi
septemb
novel
betacoronaviru
belong
lineag
c
zaki
et
al
retrospect
test
sampl
middl
east
identifi
nine
case
jordan
hijawi
et
al
diseas
consid
clinic
syndrom
rang
asymptomat
case
respiratori
failur
multisystem
organ
failur
syndrom
term
middl
eastern
respiratori
syndrom
mer
test
perform
accordingli
middl
east
return
travel
middl
east
countri
base
epidemiolog
risk
factor
second
global
case
mer
identifi
qatari
nation
previous
travel
saudi
arabia
transfer
qatar
hospit
england
clinic
deterior
place
extracorpor
membran
oxygen
ecmo
howev
unfortun
fatal
outcom
bermingham
et
al
second
case
uk
confirm
februari
return
travel
pakistan
saudi
arabia
admit
sever
acut
respiratori
symptom
patient
requir
ecmo
treatment
howev
also
unfortun
die
case
result
onward
transmiss
two
case
one
subsequ
die
health
protect
agenc
uk
novel
coronaviru
investig
team
c
august
fifth
case
mer
diagnos
return
travel
middl
east
patient
initi
admit
hospit
leed
transfer
specialist
infecti
diseas
unit
liverpool
patient
posit
outcom
onward
transmiss
merscov
close
contact
end
novemb
mer
cov
infect
peopl
case
fatal
rate
cfr
world
health
organ
w
notabl
higher
cfr
itu
set
arabi
et
al
nosocomi
outbreak
occur
saudi
arabia
south
korea
demonstr
need
stringent
infect
control
polic
park
et
al
view
high
risk
import
case
public
health
england
phe
commiss
region
center
perform
merscov
test
possibl
mer
case
arriv
england
phe
manchest
laboratori
one
two
center
current
perform
test
merscov
receiv
sampl
greater
manchest
region
surround
counti
lancashir
merseysid
cumbria
cheshir
addit
receiv
sampl
area
northwest
region
unit
kingdom
entail
counti
yorkshir
humber
also
counti
northeast
region
greater
manchest
gm
region
popul
around
million
peopl
black
minor
ethnic
popul
manchest
citi
council
like
travel
middl
east
visit
friend
famili
busi
religi
pilgrimag
tourism
gm
region
also
muslim
popul
offic
nation
statist
review
wp
greater
nation
averag
unit
kingdom
offic
nation
statist
muslim
popul
visit
kingdom
saudi
arabia
ksa
least
lifetim
holi
citi
mecca
medina
compulsori
pilgrimag
hajj
million
pilgrim
countri
attend
hajj
annual
may
result
dissemin
merscov
pathogen
multipl
countri
includ
unit
kingdom
muslim
also
travel
ksa
umrah
minipilgrimag
ramadan
may
increas
possibl
spread
mer
manchest
uk
third
busiest
airport
uk
civil
aviat
author
c
around
million
passeng
process
special
adapt
accommod
airbu
capac
passeng
per
flight
result
signific
proport
passeng
return
middl
east
greater
manchest
region
manchest
also
host
northwest
region
tertiari
infecti
diseas
unit
region
infecti
diseas
unit
ridu
north
manchest
gener
hospit
accept
direct
admiss
return
travel
fever
consequ
assess
multitud
patient
possibl
merscov
infect
phe
manchest
laboratori
work
close
ridu
provid
servic
present
detail
analysi
result
surveil
merscov
test
phe
manchest
laboratori
initi
septemb
februari
initi
test
carri
first
merscov
case
identifi
uk
paus
test
june
septemb
test
carri
phe
birmingham
septemb
februari
return
travel
present
hospit
north
west
region
respiratori
symptom
middl
east
risk
assess
potenti
merscov
infect
risk
assess
perform
util
phe
mer
criteria
possibl
case
defin
person
sever
acut
respiratori
infect
requir
admiss
hospit
symptom
fever
c
histori
fever
evid
pulmonari
parenchym
diseas
least
one
follow
histori
travel
resid
area
infect
merscov
could
acquir
symptom
onset
close
contact
onset
ill
symptomat
confirm
case
merscov
infect
person
healthcar
worker
base
icu
care
patient
sever
acut
respiratori
infect
regardless
travel
ppe
use
part
cluster
two
epidemiolog
link
case
within
twoweek
period
requir
icu
admiss
regardless
histori
travel
acut
influenzalikeil
symptom
ili
contact
camel
camel
environ
consumpt
camel
product
prior
onset
acut
respiratori
ill
ari
contact
confirm
case
merscov
day
prior
onset
meet
phe
case
definit
discuss
region
infecti
diseas
team
andor
consult
virologist
test
infect
phe
phe
figur
major
case
initi
discuss
ridu
team
transfer
north
manchest
gener
hospit
assess
neg
pressur
room
appropri
person
protect
equip
ppe
use
local
hospit
case
discuss
directli
phe
manchest
consult
virologist
scenario
risk
assess
directli
carri
phe
virologist
advic
infect
control
use
ppe
ffp
mask
given
reduc
chanc
nosocomi
transmiss
case
test
found
posit
figur
local
health
protect
team
involv
throughout
process
time
present
refer
hospit
result
test
data
extract
laboratori
inform
manag
system
lim
ms
excel
initi
screen
data
extract
analys
spss
utilis
spss
tableau
desktop
result
figur
produc
respiratori
sampl
taken
refer
physician
patient
whilst
ppe
upper
respiratori
tract
urt
sampl
nose
throat
swab
nasopharyng
aspir
lower
respiratori
tract
lrt
sampl
sputum
bronchoalveolar
lavag
submit
addit
clot
blood
also
request
store
possibl
serolog
test
futur
sampl
urin
legionella
pneumococc
antigen
urt
lrt
sampl
bacteri
cultur
submit
investig
pathogen
sampl
process
appropri
contain
level
accord
nation
guidanc
sampl
transport
pack
accord
categori
b
biolog
substanc
regul
public
health
england
p
urt
lrt
sampl
initi
test
mer
cov
quantit
real
time
revers
transcript
polymeras
chain
assay
verif
ce
mark
commerci
avail
test
kit
merscov
across
five
phe
laboratori
led
select
altona
realstar
mer
rtpcr
kit
patient
test
januari
diagnost
sampl
also
test
influenza
flu
influenza
b
flu
b
respiratori
syncyti
viru
rsv
rhinovirus
adenoviru
adeno
human
metapneumoviru
mpv
parainfluenza
viru
pf
type
test
perform
use
mixtur
triplex
fluaflubrsv
duplex
adeno
rhino
singleplex
mpv
pcr
assay
four
hundr
twentysix
sampl
receiv
two
hundr
sixtyfour
patient
fulfil
criteria
mer
cov
test
phe
case
definit
algorithm
phe
phe
figur
sampl
sent
locat
throughout
northwest
england
major
sent
region
infecti
diseas
unit
univers
teach
hospit
supplementari
figur
patient
age
rang
week
year
old
patient
demograph
characterist
shown
tabl
fiftyf
percent
patient
asian
background
arab
caucasian
background
respect
supplementari
figur
travel
histori
note
lim
system
request
form
show
major
patient
return
ksa
uae
refaey
et
al
demonstr
figur
supplementari
figur
sampl
posit
viral
pathogen
neg
via
viral
pcr
test
consid
bacteri
origin
supplementari
figur
note
sampl
posit
dual
viral
infect
sampl
posit
tripl
viral
infect
supplementari
figur
major
sampl
sent
nose
throat
swab
sputum
sampl
throat
swab
demonstr
figur
sputum
sampl
highest
posit
rate
viral
pathogen
follow
bal
sampl
shown
supplementari
figur
patient
enddiagnosi
posit
viral
pathogen
sampl
sent
contrast
enddiagnosi
posit
sampl
sent
patient
supplementari
figur
four
hundr
twentysix
sampl
sent
patient
henc
result
view
accord
patient
number
percentag
total
patient
posit
microbiolog
enddiagnos
increas
figur
supplementari
figur
demonstr
number
posit
viral
result
patient
subsequ
posit
dual
tripl
viral
infect
bacteri
aetiolog
patient
patient
posit
legionella
initi
via
urinari
antigen
test
confirm
via
refer
laboratori
test
total
patient
posit
coinfect
methicillin
sensit
staphylococcu
aureu
mssa
group
g
streptococcu
rest
equal
divid
escherichia
coli
ecoli
haemophilu
influenza
pcp
mycoplasma
supplementari
figur
date
hajj
umrah
ramadan
fluctuat
everi
year
islam
calendar
lunar
base
date
usual
chang
day
annual
tabl
surveil
period
merscov
detect
phe
manchest
travel
return
middl
east
correl
phe
birmingham
data
similar
period
atabani
et
al
wider
global
find
via
prome
monitor
report
howev
discuss
previous
august
merscov
case
diagnos
posit
phe
birmingham
highlight
need
continu
vigil
phe
phe
patient
whose
travel
histori
known
major
travel
kingdom
saudi
arabia
unit
arab
emir
unfortun
patient
travel
histori
document
databas
demonstr
need
improv
travel
histori
document
clinic
laboratori
request
form
patient
travel
variou
countri
middl
east
supplementari
figur
analys
sampl
type
note
highest
posit
sputum
sampl
follow
bal
although
lowest
posit
sampl
nasopharyng
aspir
npa
number
sampl
low
consid
signific
one
npa
sampl
receiv
four
hundr
twentysix
sampl
sent
total
patient
refer
hospit
sent
multipl
sampl
per
patient
advis
ensur
pcr
confirm
enddiagnosi
patient
patient
four
sampl
sent
confirm
enddiagnosi
contrast
enddiagnosi
half
patient
one
sampl
sent
howev
limit
studi
low
number
patient
greater
four
sampl
sent
although
sampl
pcr
posit
pathogen
result
view
accord
patient
number
patient
posit
microbiolog
result
due
bacteri
investig
elicit
posit
diagnosi
higher
pathogen
posit
patient
two
sampl
sent
patient
number
common
viral
pathogen
test
patient
influenza
follow
rhinoviru
total
patient
posit
bacteri
pathogen
via
pcr
test
cultureantigen
result
phe
manchest
receiv
greatest
number
mer
cov
test
octob
correl
post
hajj
period
septemb
supplementari
figur
greatest
number
sampl
receiv
juli
supplementari
figur
correl
hajj
septemb
howev
correl
post
ramadan
period
juli
post
vacat
period
tourism
travel
dubai
uae
secondari
peak
april
could
correl
period
easter
school
holiday
april
travel
may
return
uk
travel
middl
east
tourism
purpos
peak
test
month
septemb
novemb
occur
postramadan
june
hajj
septemb
longer
incub
period
mer
may
explain
pilgrim
extend
stay
holi
festiv
eid
thu
result
possibl
increas
exposur
mersinfect
peopl
andor
camel
exposur
like
test
period
especi
travel
might
also
return
via
middl
east
summer
vacat
month
similarli
peak
test
septemb
june
correl
post
hajj
august
ramadan
june
combin
uk
school
vacat
period
result
return
travel
caus
higher
test
rate
period
clinic
spectrum
mer
broad
possibl
case
may
miss
asymptomat
patient
fit
phe
criteria
patient
attend
hospit
howev
risk
transmiss
asymptomat
case
consid
lower
symptomat
case
thu
less
need
focu
patient
public
health
perspect
moon
son
furthermor
attempt
screen
everi
travel
return
merscov
endem
countri
would
difficult
logist
financi
perspect
scenario
would
prudent
test
seropreval
merscov
travel
return
middl
east
establish
merscov
case
fit
phe
merscov
criteria
primari
find
studi
sampl
viral
aetiolog
total
patient
posit
influenza
common
viral
caus
follow
rhinoviru
although
patient
posit
merscov
posit
influenza
amongst
travel
return
middl
east
demonstr
need
carri
infect
control
measur
isol
sideroom
reduc
nosocomi
spread
influenza
respiratori
virus
also
demonstr
need
empir
use
neuraminidas
inhibitor
pend
viral
result
assess
patient
previou
studi
refaey
et
al
annan
et
al
benkouiten
et
al
assiri
et
al
zumla
et
al
middl
east
also
demonstr
high
posit
influenza
viru
return
hajj
pilgrim
give
evid
influenza
vaccin
advis
travel
peopl
consid
hajj
secondari
find
high
posit
sputum
sampl
compar
bal
sampl
previou
studi
demonstr
higher
yield
bal
test
sputum
test
sing
et
al
pcp
test
higher
yield
sputum
compar
nasopharyng
swab
falsey
et
al
studi
demonstr
higher
yield
sputum
bal
test
howev
limit
higher
number
sputum
sampl
n
submit
compar
bal
sampl
n
addit
note
sputum
pcr
posit
higher
combin
pool
posit
nose
throat
combin
nosethroat
swab
howev
total
number
sputum
sampl
receiv
compar
sampl
receiv
nose
throat
combin
nt
swab
find
demonstr
need
studi
sampl
type
pcr
posit
respiratori
virus
also
note
higher
posit
rate
higher
number
sampl
sent
refer
hospit
diagnosi
merscov
phe
manchest
request
sampl
sputum
nose
ae
throat
swab
bal
avail
clot
blood
due
high
clinic
workload
refer
hospit
receiv
variabl
number
sampl
per
patient
studi
seen
patient
greater
four
sampl
sent
demonstr
diagnost
yield
compar
one
sampl
per
patient
sent
one
specif
patient
case
six
sampl
sent
posit
influenza
conclud
observ
four
sampl
patient
taken
ensur
viral
diagnosi
although
case
mer
coronaviru
identifi
phe
manchest
major
patient
identifi
phe
mer
criteria
viral
respiratori
pathogen
neuraminidas
inhibitor
treatment
indic
nosocomi
isol
warrant
respiratori
tract
viral
infect
post
travel
middl
east
common
vaccin
influenza
strongli
recommend
peopl
travel
middl
east
religi
purpos
posit
merscov
case
august
uk
previou
devast
nosocomi
outbreak
mer
world
essenti
rais
awar
fatal
pathogen
need
continu
proactiv
investig
rapidli
identifi
isol
possibl
merscov
patient
return
middl
east
need
continu
surveil
return
travel
risk
merscov
infect
knowledg
import
syndrom
also
facilit
public
health
respons
manag
case
merscov
high
consequ
infecti
diseas
requir
highest
vigil
ensur
prevent
spread
lethal
outcom
research
receiv
specif
grant
fund
agenc
public
commerci
notforprofit
sector
author
declar
conflict
interest
anyth
declar
ethic
approv
obtain
studi
analysi
laboratori
surveil
data
howev
patient
identifi
inform
anonym
ensur
patient
confidenti
data
analysi
